세계 구획 증후군 치료 시장 – 2024-2031

Global Compartment Syndrome Treatment Market - 2024-2031

상품코드PH8567
발행기관DataM Intelligence
발행일2024.08.06
페이지 수181 Pages
포맷PDF + EXCEL
커버리지Global

₩6,525,000 – ₩11,775,000

보고서 요약(국문)

개요
전 세계 구획 증후군 치료 시장은 2023년 3억 1,680만 달러에 달했으며, 2024년부터 2031년까지 연평균 6.3%의 성장률을 보이며 2031년에는 5억 1,660만 달러에 이를 것으로 예상됩니다.
구획 증후군은 근육 내 압력이 위험한 수준으로 증가할 때 발생하는 통증성 질환입니다. 이러한 압력 증가는 혈류를 감소시켜 신경 및 근육 세포에 영양분과 산소가 공급되는 것을 방해합니다. 구획 증후군은 급성(단기간에 심한 증상이 나타남) 또는 만성(장기간 지속됨)으로 분류됩니다.
급성 구획 증후군은 수술적 치료가 필요한 응급 상황입니다. 효과적인 비수술적 치료법은 없습니다. 해당 구획을 덮고 있는 피부와 근막을 절개하는 근막절개술을 시행합니다.
만성 구획 증후군은 비수술적 치료법이 있습니다. 물리 치료, 보조기(신발 깔창), 항염증제는 증상 완화에 제한적인 효과를 보일 수 있으며, 일반적으로 완전한 활동 복귀를 보장하지는 않습니다.

구획 증후군 치료에 사용되는 약물에는 오피오이드, 비아피오이드 및 NSAID가 포함됩니다. 시장은 외상성 손상 발생률 증가 및 치료 기술의 발전과 같은 요인에 의해 주도됩니다.
시장 동향: 동인
외상성 손상 발생률 증가
전 세계 구획 증후군 치료 시장의 수요는 여러 요인에 의해 주도됩니다. 외상성 손상 발생률 증가는 시장 성장을 견인할 것으로 예상됩니다. 교통사고, 스포츠 손상, 전투 부상과 같은 외상성 손상은 구획 증후군의 주요 원인입니다.
급성 구획 증후군(ACS)은 특히 장골 골절과 같은 심각한 외상 직후에 발생하는 경우가 많습니다. 2023년 1월 Medscape 뉴스에 따르면 외상 중환자실 입원 환자의 5~15%, 일반 외상 환자 입원 환자의 1%에서 복부 구획 증후군이 발생합니다.
또한, 업계 주요 기업들의 지속적인 연구 개발 활동이 시장 성장을 촉진할 것입니다. 2024년 3월 NCBI 연구 논문에 따르면, 2015년부터 2022년까지 총 13,305건의 외상성 구획 증후군이 발생했습니다. 이 중 61%는 하지에서, 11%는 상지에서 나타났습니다. 상당수의 사례(25.2%)에서 정확한 병변 위치 분류가 이루어지지 않았습니다. 외상성 구획 증후군은 남성에게서 더 많이 발생했습니다(여성 4,092건, 남성 9,213건).
마찬가지로, 2023년 12월 EFFORT 공개 검토에 따르면, 경골 골절에서 외상성 구획 증후군의 발생률은 손상 부위에 따라 다르며, 경골 고원 골절의 경우 약 12%에서 고에너지 골절의 경우 최대 53%까지 나타납니다.
제한 요인
높은 치료 비용, 제한적인 치료 옵션, 그리고 개인의 낮은 인식 및 진단 능력과 같은 요인들이 시장 성장을 저해할 것으로 예상됩니다.

이 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세그먼트 분석
전 세계 구획 증후군 치료 시장은 치료 유형, 증후군 유형, 최종 사용자 및 지역별로 세분화됩니다.
근막절개술 부문은 전 세계 구획 증후군 치료 시장 점유율의 약 51.3%를 차지했습니다.
근막절개술 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 근막은 근육 구획을 둘러싸는 두꺼운 결합 조직입니다. 근막절개술은 근육 구획의 압력을 완화하기 위해 근막을 절개하는 시술로, 급성 또는 만성 구획 증후군 환자 치료에 사용됩니다.
근막절개술은 하나 이상의 근막 절개로 구성되며, 급성 구획 증후군을 치료하는 유일하게 효과적인 방법입니다. 근막절개술은 영향을 받은 신경이나 근육에 가해지는 압력을 완화하기 위해 피부와 아래 조직에 절개를 하는 외과적 시술입니다. 2024년 4월 Healio 뉴스에 따르면, 응급 근막절개술이 필요한 비외상성 특발성 구획 증후군이 보고되었습니다.

또한, 근막절개술 분야의 주요 시장 참여자들의 기술 발전이 시장 성장을 견인하고 있습니다. 첨단 구획 내압 모니터링 장치의 개발은 구획 증후군 진단의 정확성과 신뢰성을 향상시켜 외과의사가 근막절개술의 필요성과 시기를 결정하는 데 도움을 줍니다.
2024년 3월 NCBI에 발표된 자료에 따르면, FDA 승인을 받은 장치가 지속적인 구획 내압 모니터링에 사용되었습니다. 센서 끝을 근육 복부에 삽입한 후, 트로카를 센서에서 분리하여 센서가 제자리에 유지되도록 합니다. 휴대용 초음파 장치와 같은 영상 기술의 혁신은 근막절개술 시술 중 수술 전 계획 및 수술 중 평가에 도움이 됩니다.
지역 분석
북미는 전 세계 구획 증후군 치료 시장 점유율의 약 43.8%를 차지했습니다.

NCBI(2024년 4월)에 따르면, 북미 지역은 외상 및 스포츠 관련 부상 발생률이 높아 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 급성 관상동맥 증후군(ACS) 발생률은 남성 10만 명당 7.3명, 여성 10만 명당 0.7명으로 추정됩니다.
미국 국가안전위원회(NSC)에 따르면, 2023년에는 370만 명이 스포츠 및 레크리에이션 장비 관련 부상으로 응급실에서 치료를 받았습니다. 부상 발생률이 가장 높은 활동은 운동, 자전거 타기, 농구입니다. 미국 어린이와 청소년의 스포츠 및 레크리에이션 활동은 시장 성장에 기여하고 있습니다.
또한, 주요 업체들의 혁신적인 노력, 증후군에 대한 인식 증가, 의료 기술의 발전, 스포츠 의학에 대한 관심 증대가 이 지역 시장 성장을 견인하고 있습니다. 예를 들어, 2023년 8월 Sentinel Medical Technologies는 외상 병동의 복강 내압(IAP) 변환기 부족 문제를 해결했습니다. IAP 모니터링은 수술실과 중환자실에서 환자 치료에 매우 중요한 요소입니다. 이는 의료진이 복강 내 고혈압(IAH) 및 복부 구획 증후군(ACS) 발생 위험을 평가하는 데 중요한 지침 역할을 하며, 이러한 질환은 신속하게 치료하지 않으면 심각한 결과를 초래할 수 있습니다.
시장 세분화
치료 유형별
• 근막절개술
• 보조기
• 약물
o 오피오이드
o 비오피오이드
o NSAID
증상 유형별
• 급성 구획 증후군
• 만성 구획 증후군
최종 사용자별
• 병원 및 클리닉
• 외래 수술 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 한국
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
구획 증후군 치료 시장의 주요 글로벌 업체로는 Stryker, BD, C2DX, Inc., Accuryn Medical, Medline Industries, LP. 등이 있습니다. MY01, Convatec Inc., RAUMEDIC AG, Millar, LLC, Mirador Biomedical 등이 주요 기업입니다.

주요 개발 사항
 2021년 5월, MY01 Inc.는 구획 증후군 진단 보조 장치인 MY01 연속 구획 압력 모니터에 대해 FDA 승인을 받았습니다.
보고서 ​​구매 이유

• 치료 유형, 증후군 유형, 최종 사용자 및 지역별 글로벌 구획 증후군 치료 시장 세분화를 시각화하고 주요 상업적 자산과 기업을 파악합니다.

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 구획 증후군 치료 시장의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 구획 증후군 치료 시장 보고서는 약 62개의 표, 58개의 그림, 181페이지 분량입니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The global compartment syndrome treatment market reached US$ 316.8 million in 2023 and is expected to reach US$ 516.6 million by 2031 growing with a CAGR of 6.3% during the forecast period 2024-2031.
Compartment syndrome is a painful condition that occurs when pressure within the muscles builds to dangerous levels. This pressure can decrease blood flow, which prevents nourishment and oxygen from reaching nerve and muscle cells. Compartment syndrome can be either acute (having severe symptoms for a short period) or chronic (long-lasting).
Acute compartment syndrome is a surgical emergency. There is no effective nonsurgical treatment. An incision and cut open the skin and fascia covering the affected compartment. This procedure is called a fasciotomy.
Chronic compartment syndrome is a nonsurgical treatment. Physical therapy, orthotics (inserts for shoes), and anti-inflammatory medicines may be of limited benefit in relieving symptoms and generally do not allow a return to full activity.
Drugs used for comportment syndrome treatment involve opioids, non-opioids, and NSAIDs. The market is driven by factors such as the increasing incidence of traumatic injuries and technological advancements in treatment.
Market Dynamics: Drivers
Increasing incidence of traumatic injuries
The demand for the global compartment syndrome treatment market is driven by multiple factors. The increasing incidence of traumatic injuries is expected to drive the growth of the market. Traumatic injuries, such as road accidents, sports injuries, and combat injuries, are major causes of compartment syndrome.
Acute compartment syndrome (ACS) most often develops soon after significant trauma, particularly involving long bone fractures. According to Medscape news in January 2023, the frequency of abdominal compartment syndrome in trauma ICU admissions is anywhere from 5 to 15% and 1% of general trauma admissions.
Moreover, major players in the industry's ongoing research studies would propel this market growth. According to an NCBI research publication in March 2024, during the period from 2015 to 2022, a total of 13,305 cases of traumatic compartment syndromes. Of these, 61% manifested in the lower extremities and 11% in the upper extremities. A significant portion of cases lacked precise localization classification (25.2%). Most traumatic compartment syndromes occurred in males (4092 cases in females vs. 9213 in males).
Similarly, as per EFFORT open reviews in December 2023, ACS in tibial fractures varies depending on the injury site, around 12% for tibial plateau fractures, reaching up to 53% in higher-energy patterns.
Restraints
Factors such as the high cost of treatment, the availability of limited treatment options, and limited awareness & diagnosis among individuals, are expected to hamper the market.
For more details on this report - Request for Sample
Segment Analysis
The global compartment syndrome treatment market is segmented based on treatment type, syndrome type, end-users, and region.
The fasciotomy segment accounted for approximately 51.3% of the global compartment syndrome treatment market share
The fasciotomy segment is expected to hold the largest market share over the forecast period. Fascia are the thick sheets of connective tissue that surround muscle compartments. Fasciotomy, a procedure in which the fascia is cut to relieve pressure in the muscle compartment, is used to treat people with acute or chronic compartment syndrome.
A fasciotomy consists of 1 or more fascial incisions and remains the only effective way to treat acute compartment syndrome. Fasciotomy is a surgical procedure that involves making an incision in the skin and underlying tissue to relieve pressure on the affected nerve or muscle. According to Healio news in April 2024, Atraumatic idiopathic compartment syndrome requiring emergent fasciotomy.
Moreover, key players in the market technological advancements in fasciotomy drive the market growth. The development of advanced intracompartmental pressure monitoring devices enhances the accuracy and reliability of diagnosing compartment syndrome, guiding surgeons in determining the necessity and timing of fasciotomy.
As per NCBI publication in March 2024, an FDA-approved device was used for continuous compartment pressure monitoring. The sensor tip is placed in the muscle belly, and the trochar is then detached from the sensor, allowing the sensor to remain in place. Innovations in imaging technologies, such as portable ultrasound devices, aid in pre-operative planning and intraoperative assessment during fasciotomy procedures.
Geographical Analysis
North America accounted for approximately 43.8% of the global compartment syndrome treatment market share.
North America region is expected to hold the largest market share over the forecast period owing to the high incidence of trauma and sports-related injuries as per NCBI April 2024, the incidence of ACS is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females.
According to the National Safety Council in 2023, 3.7 million people were treated in emergency departments for injuries involving sports and recreational equipment. The activities most frequently associated with injuries are exercise, cycling, and basketball. Amongst American children and adolescents, sports and recreational activities contribute to the growth of the market.
Moreover, key player's innovative initiatives, growing awareness of the syndrome, advancements in medical technology, and increased focus on sports medicine propel this market growth in this region. For instance, in August 2023, Sentinel Medical Technologies addressed the IAP transducer shortage with the trauma ward. IAP monitoring is a critical component of patient care in OR and ICU settings. It serves as a crucial guide for medical teams in assessing the risk of developing Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS), conditions that can have severe consequences if not addressed promptly.
Market Segmentation
By Treatment Type
• Fasciotomy
• Orthotics
• Drugs
o Opioids
o Non-Opioids
o NSAIDs
By Syndrome Type
• Acute Compartment Syndrome
• Chronic Compartment Syndrome
By End-User
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o The rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the compartment syndrome treatment market include Stryker, BD, C2DX, Inc., Accuryn Medical, Medline Industries, LP., MY01, Convatec Inc., RAUMEDIC AG, Millar, LLC, and Mirador Biomedical among others.
Key Developments
 In May 2021, MY01 Inc. received FDA clearance for the MY01 continuous compartment pressure monitor as an aid in the diagnosis of compartment syndrome.
Why Purchase the Report?
• To visualize the global compartment syndrome treatment market segmentation based on treatment type, syndrome type, end-users, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the compartment syndrome treatment market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.
The global compartment syndrome treatment market report would provide approximately 62 tables, 58 figures, and 181 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Treatment Type
3.2. Snippet by Syndrome Type
3.3. Snippet by End-Users
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Incidence of Traumatic Injuries
4.1.1.2. Technological Advancements in Treatment
4.1.2. Restraints
4.1.2.1. High Cost of Treatment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Treatment Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
6.1.2. Market Attractiveness Index, By Treatment Type
6.2. Fasciotomy *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Orthotics
6.4. Drugs
6.4.1. Opioids
6.4.2. Non-Opioids
6.4.3. NSAIDs
7. By Syndrome Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type Market Attractiveness Index, By Syndrome Type
7.2. Acute Compartment Syndrome*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chronic Compartment Syndrome
8. By End-Users
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
8.1.2. Market Attractiveness Index, By End-Users
8.2. Hospitals & Clinics *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Syndrome Type
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Stryker *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. BD
11.3. C2DX, Inc
11.4. Accuryn Medical
11.5. Medline Industries, LP.
11.6. MY01
11.7. Convatec Inc
11.8. RAUMEDIC AG
11.9. Millar, LLC
11.10. Mirador Biomedical
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

Stryker, 4. Key Developments, BD, C2DX, Inc, Accuryn Medical, Medline Industries, LP., MY01, Convatec Inc, RAUMEDIC AG, Millar, LLC, Mirador Biomedical

표 목록 (Tables)

List of Tables

Table 1 Global Compartment Syndrome Treatment Market Value, By Treatment Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Compartment Syndrome Treatment Market Value, By Syndrome Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Compartment Syndrome Treatment Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Compartment Syndrome Treatment Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Compartment Syndrome Treatment Market Value, By Treatment Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Compartment Syndrome Treatment Market Value, By Treatment Type, 2022-2031 (US$ Million)

Table 7 Global Compartment Syndrome Treatment Market Value, By Syndrome Type, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Compartment Syndrome Treatment Market Value, By Syndrome Type, 2022-2031 (US$ Million)

Table 9 Global Compartment Syndrome Treatment Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Compartment Syndrome Treatment Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Compartment Syndrome Treatment Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Compartment Syndrome Treatment Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Compartment Syndrome Treatment Market Value, By Treatment Type, 2022-2031 (US$ Million)

Table 14 North America Compartment Syndrome Treatment Market Value, By Syndrome Type, 2022-2031 (US$ Million)

Table 15 North America Compartment Syndrome Treatment Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Compartment Syndrome Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 17 Asia-Pacific Compartment Syndrome Treatment Market Value, By Treatment Type, 2022-2031 (US$ Million)

Table 18 Asia-Pacific Compartment Syndrome Treatment Market Value, By Syndrome Type, 2022-2031 (US$ Million)

Table 19 Asia-Pacific Compartment Syndrome Treatment Market Value, By End User, 2022-2031 (US$ Million)

Table 20 Asia-Pacific Compartment Syndrome Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Compartment Syndrome Treatment Market Value, By Treatment Type, 2022-2031 (US$ Million)

Table 22 Europe Compartment Syndrome Treatment Market Value, By Syndrome Type, 2022-2031 (US$ Million)

Table 23 Europe Compartment Syndrome Treatment Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Compartment Syndrome Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 25 South America Compartment Syndrome Treatment Market Value, By Treatment Type, 2022-2031 (US$ Million)

Table 26 South America Compartment Syndrome Treatment Market Value, By Syndrome Type, 2022-2031 (US$ Million)

Table 27 South America Compartment Syndrome Treatment Market Value, By End User, 2022-2031 (US$ Million)

Table 28 South America Compartment Syndrome Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East and Africa Compartment Syndrome Treatment Market Value, By Treatment Type, 2022-2031 (US$ Million)

Table 30 Middle East and Africa Compartment Syndrome Treatment Market Value, By Syndrome Type, 2022-2031 (US$ Million)

Table 31 Middle East and Africa Compartment Syndrome Treatment Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Middle East and Africa Compartment Syndrome Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 33 Stryker: Overview

Table 34 Stryker: Product Portfolio

Table 35 Stryker: Key Developments

Table 36 BD: Overview

Table 37 BD: Product Portfolio

Table 38 BD: Key Developments

Table 39 C2DX, Inc: Overview

Table 40 C2DX, Inc: Product Portfolio

Table 41 C2DX, Inc: Key Developments

Table 42 Accuryn Medical: Overview

Table 43 Accuryn Medical: Product Portfolio

Table 44 Accuryn Medical: Key Developments

Table 45 Medline Industries, LP: Overview

Table 46 Medline Industries, LP: Product Portfolio

Table 47 Medline Industries, LP: Key Developments

Table 48 MY01: Overview

Table 49 MY01: Product Portfolio

Table 50 MY01: Key Developments

Table 51 Convatec Inc: Overview

Table 52 Convatec Inc: Product Portfolio

Table 53 Convatec Inc: Key Developments

Table 54 RAUMEDIC AG: Overview

Table 55 RAUMEDIC AG: Product Portfolio

Table 56 RAUMEDIC AG: Key Developments

Table 57 Millar, LLC: Overview

Table 58 Millar, LLC: Product Portfolio

Table 59 Millar, LLC: Key Developments

Table 60 Mirador Biomedical: Overview

Table 61 Mirador Biomedical: Product Portfolio

Table 62 Mirador Biomedical: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 2 Global Compartment Syndrome Treatment Market Share, By Treatment Type, 2023 & 2031 (%)

Figure 3 Global Compartment Syndrome Treatment Market Share, By Syndrome Type, 2023 & 2031 (%)

Figure 4 Global Compartment Syndrome Treatment Market Share, By End User, 2023 & 2031 (%)

Figure 5 Global Compartment Syndrome Treatment Market Share, By Region, 2023 & 2031 (%)

Figure 6 Global Compartment Syndrome Treatment Market Y-o-Y Growth, By Treatment Type, 2023-2031 (%)

Figure 7 Fasciotomy Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 8 Orthotics Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 9 Drugs Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 10 Opioids Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 11 Non-Opioids Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 12 NSAIDs Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 13 Global Compartment Syndrome Treatment Market Y-o-Y Growth, By Syndrome Type, 2023-2031 (%)

Figure 14 Acute Compartment Syndrome Syndrome Type in Global Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 15 Chronic Compartment Syndrome Syndrome Type in Global Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 16 Global Compartment Syndrome Treatment Market Y-o-Y Growth, By End User, 2023-2031 (%)

Figure 17 Hospitals & Clinics End User in Global Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 18 Ambulatory Surgical Centers End User in Global Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 19 Others End User in Global Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 20 Global Compartment Syndrome Treatment Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 21 North America Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 22 North America Compartment Syndrome Treatment Market Share, By Treatment Type, 2023 & 2031 (%)

Figure 23 North America Compartment Syndrome Treatment Market Share, By Syndrome Type, 2023 & 2031 (%)

Figure 24 North America Compartment Syndrome Treatment Market Share, By End User, 2023 & 2031 (%)

Figure 25 North America Compartment Syndrome Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 26 Asia-Pacific Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 27 Asia-Pacific Compartment Syndrome Treatment Market Share, By Treatment Type, 2023 & 2031 (%)

Figure 28 Asia-Pacific Compartment Syndrome Treatment Market Share, By Syndrome Type, 2023 & 2031 (%)

Figure 29 Asia-Pacific Compartment Syndrome Treatment Market Share, By End User, 2023 & 2031 (%)

Figure 30 Asia-Pacific Compartment Syndrome Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 31 Europe Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 32 Europe Compartment Syndrome Treatment Market Share, By Treatment Type, 2023 & 2031 (%)

Figure 33 Europe Compartment Syndrome Treatment Market Share, By Syndrome Type, 2023 & 2031 (%)

Figure 34 Europe Compartment Syndrome Treatment Market Share, By End User, 2023 & 2031 (%)

Figure 35 Europe Compartment Syndrome Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 36 South America Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 37 South America Compartment Syndrome Treatment Market Share, By Treatment Type, 2023 & 2031 (%)

Figure 38 South America Compartment Syndrome Treatment Market Share, By Syndrome Type, 2023 & 2031 (%)

Figure 39 South America Compartment Syndrome Treatment Market Share, By End User, 2023 & 2031 (%)

Figure 40 South America Compartment Syndrome Treatment Market Share, By Country, 2023 & 2031 (%)

Figure 41 Middle East and Africa Compartment Syndrome Treatment Market Value, 2022-2031 (US$ Million)

Figure 42 Middle East and Africa Compartment Syndrome Treatment Market Share, By Treatment Type, 2023 & 2031 (%)

Figure 43 Middle East and Africa Compartment Syndrome Treatment Market Share, By Syndrome Type, 2023 & 2031 (%)

Figure 44 Middle East and Africa Compartment Syndrome Treatment Market Share, By End User, 2023 & 2031 (%)

Figure 45 Stryker: Financials

Figure 46 BD: Financials

Figure 47 C2DX, Inc: Financials

Figure 48 Accuryn Medical: Financials

Figure 49 Medline Industries, LP: Financials

Figure 50 MY01: Financials

Figure 51 Convatec Inc: Financials

Figure 52 RAUMEDIC AG: Financials

Figure 53 Millar, LLC: Financials

Figure 54 Mirador Biomedical: Financials